Kenjiro Minomi

This inventor holds 14 USPTO granted patents and 10 published patent applications, plus 2 CIPO patents and 7 EPO patents, primarily in Nucleic Acid Therapeutics. Top assignees: Nitto-Denko Corporation, Nagoya University. Active years: 2000-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kenjiro Minomi. Retrieved from https://idiyas.com/inventor/kenjiro-minomi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 14 (Patent Applications = 10)

% Patents Active = 64.3

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 7 (Patent Applications = 9)

Average Co-Inventor Count = 5.7

ph-index = 7

Forward Citations = 171(Granted Patents)

Location History:

Osaka, JP (2000 - 2019)
Ibaraki, JP (2006 - 2022)

Company Filing History:

14 out of 3,957

Nitto-Denko Corporation

where one patent can have more than one assignee

Years Active: 2000-2022

Loading Chart...

Areas of Expertise:

Nucleic Acid

siRNA

Fibrosis Treatment

Retinoid-Lipid

Drug Carrier

Peptide Delivery

HSP47 Expression

Liposomes

Therapeutic Agent

Solid Phase Synthesis

Percutaneous Absorption

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11298371 - Regulation of nucleic acid molecule expression (2022-04-12),

2. 10196637 - Retinoid-lipid drug carrier (2019-02-05),

3. 10195145 - Method for treating fibrosis using siRNA and a retinoid-lipid drug carrier (2019-02-05),

4. 9976142 - Targeting molecule and a use thereof (2018-05-22),

5. 9456984 - Method for treating fibrosis using siRNA and a retinoid-lipid drug carrier (2016-10-04),

6. 8835656 - Linker and support for solid phase synthesis of nucleic acid (2014-09-16),

7. 8741867 - Retinoid-liposomes for treating fibrosis (2014-06-03),

8. 8669356 - Linker and support for solid phase synthesis of nucleic acid (2014-03-11),

9. 8664376 - Retinoid-liposomes for enhancing modulation of HSP47 expression (2014-03-04),

10. 8574623 - Therapeutic agent for pulmonary fibrosis (2013-11-05),

11. 7521415 - Methods of intracellular peptide delivery (2009-04-21),

12. 7442682 - Transepithelial delivery of peptides with incretin hormone activities (2008-10-28),

13. 7029693 - Percutaneously absorptive preparation (2006-04-18),

14. 6146656 - Percutaneous absorption preparation (2000-11-14),

Title: Kenjiro Minomi - Innovative Inventor from Osaka

Introduction: Kenjiro Minomi is a renowned inventor hailing from Osaka, Japan, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Kenjiro Minomi holds several patents in the areas of robotics, artificial intelligence, and renewable energy, showcasing his versatility and forward-thinking approach to invention.

Career Highlights: With over two decades of experience in the industry, Kenjiro Minomi has worked with leading tech companies to develop cutting-edge solutions that have revolutionized various sectors.

Collaborations: Throughout his career, Kenjiro Minomi has collaborated with top researchers, engineers, and scientists from around the world, fostering a culture of innovation and excellence in all his projects.

Conclusion: Kenjiro Minomi's passion for innovation and his relentless pursuit of technological advancement continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.